Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival

doi:10.3748/wjg.v20.i6.1585

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 6

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6094)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

428

WORD

224

HTML

2973

Figures (1-3)

406

Tables (1-1)

323

Sum=4354

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

814

Download

926

Sum=1740

Feb 14, 2014 (publication date) through Apr 28, 2025

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 14, 2014; 20(6): 1585-1593
Published online Feb 14, 2014. doi: 10.3748/wjg.v20.i6.1585

Full Size Figure Download Figure

Figure 3 Cumulative disease-free survival of the 34 patients with early hepatocellular carcinoma treated with radio frequency ablation.

Citation: Kikuchi L, Menezes M, Chagas AL, Tani CM, Alencar RS, Diniz MA, Alves VA, D’Albuquerque LAC, Carrilho FJ. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival. World J Gastroenterol 2014; 20(6): 1585-1593
URL: https://www.wjgnet.com/1007-9327/full/v20/i6/1585.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i6.1585